Hormonal Contraceptive Market to Reach $20.67 Bn, Globally, by 2030 at 3.3% CAGR: Allied Market Research

Health issues associated with teenage pregnancies, increase in awareness about modern contraception methods, and rise in use of oral pills as a key method to prevent unplanned pregnancy drive the growth of the global hormonal contraceptive market.

PORTLAND, Ore., March 21, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Hormonal Contraceptives Market by Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, and Transdermal Patches), Hormones (Progestin-Only Contraceptive and Combined Hormonal Contraceptive), Age Group (15–24 Years, 25–34 Years, 35–44 Years, and Above 44 Years) End User (Hospitals, Household, and Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030". According to the report, the global hormonal contraceptive industry generated $15.02 billion in 2020, and is anticipated to generate $20.67 billion by 2030, witnessing a CAGR of 3.3% from 2021 to 2030.

For Right Perspective, Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/4574

Prime determinants of growth

Health issues associated with teenage pregnancies, increase in awareness about modern contraception methods, and rise in use of oral pills as a key method to prevent unplanned pregnancy drive the growth of the global hormonal contraceptive market. However, availability of alternate contraceptive methods, health risks associated with use of contraceptives, and lack of social acceptance hinder the market growth. On the other hand, increase in focus toward family planning presents new opportunities in the coming years.

Covid-19 Scenario

• The outbreak of the COVID-19 pandemic has had a slight negative impact on the growth of the global hormonal contraceptive market, especially during the initial phase.
• For instance, according to the UNFPAs, family planning activities were largely disrupted or declined by 3.6% in 2020 as compared to previous year. Thus, aforementioned factors led to decline in demand for hormonal contraception products.

The 15 to 24 years segment to maintain its leadership status throughout the forecast period

Based on technology, the 15 to 24 years segment held the highest market share in 2020, accounting for nearly half of the global hormonal contraceptive market, and is estimated to maintain its leadership status throughout the forecast period. This is due to increase in awareness of oral pills among adults. However, the above 44 years segment is expected to portray the largest CAGR of 4.3% from 2021 to 2030.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/4574

The household segment to maintain its lead position during the forecast period

Based on end user, the household segment accounted for the largest share in 2020, contributing to more than two-thirds of the global hormonal contraceptive market, and is projected to maintain its lead position during the forecast period. Moreover, the same segment is expected to portray the largest CAGR of 3.6% from 2021 to 2030. This is attributed to easy and simple mode of administration and ease in availability of a wide range of products. The research also analyzes the segments including hospitals and clinics.

North America to maintain its dominance by 2030

Based on region, North America held the highest market share in terms of revenue 2020, accounting for nearly two-fifths of the global hormonal contraceptive market. This is due to high per capita income, strong presence of key market players, higher awareness about sexual health, and large number of unintended pregnancies. Moreover, the Asia-Pacific region is expected to witness the fastest CAGR of 4.5% during the forecast period. Large fertile population, introduction of new female contraception devices, rise in investment by market players, and strong economic growth are the major factors supplementing the regional growth.

Leading Market Players

• Female Health Company
• Teva Pharmaceutical Industries Limited
• Bayer AG, Pfizer, Inc.
• Mylan N.V.
• Johnson & Johnson
• Ansell LTD.
• Mayer Laboratories
• Merck & Co., Inc.,
• Church & Dwight, Co., Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Gene Therapy Market Expected to Reach $6,205.85 Million by 2028

Brain Health Supplements Market Expected to Reach $19.73 Billion by 2030

Optical Imaging Market Expected to Reach $3.86 Billion by 2030

Cell Culture Market Expected to Reach $36.92 Billion by 2028

Pharmaceutical Filtration Market Expected to Reach $7.74 Billion by 2028

Disposable syringes Market Expected to Grow $8 Billion by 2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg